Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: which parameter at which time-point does matter?

Source:http://linkedlifedata.com/resource/pubmed/id/20882527

Download in:

View as

General Info

PMID
20882527